Avi Geller - 19 Aug 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Reporting relationship: Member of 10% owner group
Issuer ticker: KTTA
Reported as of: 19 Aug 2022
Net transaction value: +$70,939
SEC form: 4
Accepted by SEC: 26 Aug 2022, 16:30:45 UTC
Prior SEC filing: 15 Aug 2022
Next SEC filing: 17 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Avi Geller

Key filing fact

Avi Geller filed Form 4 for Pasithea Therapeutics Corp. (KTTA) on 26 Aug 2022.

Key facts

This page summarizes Avi Geller's Form 4 filing for Pasithea Therapeutics Corp. (KTTA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Aug 2022, 16:30.

Change

Previous filing in this sequence was filed on 15 Aug 2022.
Current net transaction value: +$70,939.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KTTA transaction

Common Stock

Purchase

Transaction value: $70,939
Shares: +54,644
Change %
Price: $1.30
Shares after: 54,644
Date: 19 Aug 2022
Ownership: See footnote
Footnotes: F1

KTTA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,034,702
Date: 19 Aug 2022
Ownership: See footnote
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares are held by Leonite Fund I, LP. Avi Geller is the Managing Member of Leonite Advisors LLC, which is the General Partner of Leonite Fund I, LP.

Footnote F2

The shares are held by Leonite Capital LLC, of which Avi Geller serves as Chief Investment Officer.